Dr Amber Michelle Hill
Dr Amber Michelle Hill’s academic background is in translational neuroscience and her social impact background is focused on creative and digital strategies in healthcare to improve outcomes. Her interest in practical applications of research, development and data science has led her to engineering and entrepreneurship. Amber has co-designed and implemented research impact programmes in the UK, Germany, the United States, China and Africa. Her work has been featured in the Lancet Neurology, and on BBC London and ITV London. She has written and implemented strategies on several awards collectively totalling over £23.6 million for some of the most cited and distinguished neuroscientists and industries in the world. Amber has been accepted into the UK Government’s Department for International Trade’s Global Entrepreneur Programme and she is currently a Fellow at the Royal Society of Arts and an Enterprise Fellow at the Royal Academy of Engineering.
Translational Neuroscience
Amber enjoys translational neuroscience and improving the sustainability of research and development (R&D) industries and education. Translational neuroscience is a broad field, where Amber’s work includes research, medical devices, digital technology and healthcare innovation. Research: Amber holds a PhD in Biomedical Neuroscience from the University College London. Amber’s PhD was a translational neuroimaging and histology project focused on monitoring early biomarkers in multiple sclerosis using 9.4T magnetic resonance imaging, spectroscopy, and laboratory techniques. Devices: As a spin-off from her PhD, Amber tested the commercialisation potential of a neurological deficit scoring kit, a pre-clinical device that she developed during her research to standardise and improve the efficiency of monitoring neurological deficits pre-clinically. Healthcare: Amber is also developing new software to shape future research developments for clinical trials and other research areas, to improve outcomes. She has recently developed and tested the technology and tools it uses with researchers, clinical staff, patients and public. The technology aims to help improve outcomes and widen access to research.
Social Impact
Amber has developed a niche for bridging neuroscience, creative strategies and technology to achieve positive outcomes in research and development. She aims to improve the lives of people affected by debilitating diseases, and healthcare more broadly. She is the founder of a nonprofit social enterprise called Movement for Hope (MfH). MfH collaboratively designs art-science events that support neurology and people with brain and spinal illnesses. The organisation specialises in services dedicated to patient and public engagement, involvement and research communications. She has received several awards and honours for her research, engagement work, and business ideas. For more on this, please see Awards and Honours.
updated 2018